ISSUE: 1999/01/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers

References: Basic Science / Neuroblastoma Research

References: Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Previous Issue of Recent Publications (1998/12/a)

Next Issue of Recent Publications (1999/02/a)

Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Cabral DA, et al. Malignancies in children who initially present with rheumatic complaints. J Pediatr. 1999 Jan;134(1):53-57.    [Related articles]

Chen AR. High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results. Pediatr Transplant. 1999;3 Suppl 1:78-86.    [Related articles]

Erttmann R, et al. 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE). Eur J Cancer. 1998 Aug;34(9):1391-7.    [Related articles]     Screening

Fukuda M, et al. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating Int J Mol Med. 1998 Oct;2(4):471-475.    [Related articles]

Hochholzer L, et al. Primary pulmonary ganglioneuroblastoma: A clinicopathologic and immunohistochemical study of two cases. Ann Diagn Pathol. 1998 Jun;2(3):154-8.    [Related articles]

Kaneko M, et al. Complete resection is not required in patients with neuroblastoma under 1 year of age. J Pediatr Surg. 1998 Nov;33(11):1690-4.    [Related articles]

Kats S, et al. Severe muscle weakness secondary to paraneoplastic hypophosphatemia in neuroblastoma. Neth J Med. 1998 Nov;53(5):207-11.    [Related articles]

Keshelava N, et al. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res. 1998 Dec 1;58(23):5396-405.    [Related articles]

Kushner BH, et al. Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. J Clin Oncol. 1998 Dec;16(12):3880-9.    [Related articles]

Leung W, et al. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov;22(10):971-9.    [Related articles]

Matsushima S, et al. Peripheral neuroblastoma in a young Beagle dog. Toxicol Pathol. 1998 Nov-Dec;26(6):806-9.    [Related articles]

Mejia C, et al. Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma. Oncol Rep. 1999 Jan;6(1):149-153.    [Related articles]

Suita S, et al. Mass screening for neuroblastoma at 6 months of age: difficult to justify. J Pediatr Surg. 1998 Nov;33(11):1674-8.    [Related articles]     Screening

Takita J, et al. The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients. Oncogene. 1998 Dec 17;17(24):3137-43.    [Related articles]

Yokomori K, et al. A new technique applicable to pediatric laparoscopic surgery: abdominal wall 'area lifting' with subcutaneous wiring. J Pediatr Surg. 1998 Nov;33(11):1589-92.    [Related articles]

Basic Science / Neuroblastoma Research

Araya R, et al. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett. 1998 Nov 13;439(1-2):168-72.    [Related articles]

Berger K, et al. Binding of enterostatin to the human neuroepithelioma cell line SK-N-MC. Peptides. 1998;19(9):1525-31.    [Related articles]

Choi DK, et al. Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells. Gene. 1998 Nov 26;223(1-2):21-31.    [Related articles]

El-Agnaf OM, et al. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett. 1998 Nov 27;440(1-2):71-5.    [Related articles]

Gluer S, et al. Polysialylated neural cell adhesion molecule in childhood ganglioneuroma and neuroblastoma of different histological grade and clinical stage. Langenbecks Arch Surg. 1998 Oct;383(5):340-4.    [Related articles]

Heinroth-Hoffmann I, et al. Mechanism of ET(A)-receptor stimulation-induced increases in intracellular Ca2+ in SK-N-MC cells. Br J Pharmacol. 1998 Nov;125(6):1202-11.    [Related articles]

Hiwasa T, et al. Down-regulation of protein kinase C alpha and gamma and enhanced TPA-induced neurite formation in DAN-transfected neuroblastoma cells. FEBS Lett. 1998 Nov 27;440(1-2):25-8.    [Related articles]

Hiwasa T, et al. Isolation of a variant which has reduced Src activity from SH-SY5Y neuroblastoma cells. Anticancer Res. 1998 Sep-Oct;18(5A):3311-4.    [Related articles]

Inada H, et al. cAMP regulates nitric oxide production and ouabain sensitive Na+, K+-ATPase activity in SH-SY5Y human neuroblastoma cells. Diabetologia. 1998 Dec;41(12):1451-8.    [Related articles]

Kitamura Y, et al. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. Mol Pharmacol. 1998 Dec;54(6):1046-54.    [Related articles]

Komuro H, et al. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. J Pediatr Surg. 1998 Nov;33(11):1695-8.    [Related articles]     MYCN Amplification Chromosome 1p

Kuner P, et al. Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. J Neurosci Res. 1998 Dec 15;54(6):798-804.    [Related articles]

Liu X, et al. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res. 1998 Dec 1;58(23):5432-8.    [Related articles]

Nicole A, et al. Direct evidence for glutathione as mediator of apoptosis in neuronal cells. Biomed Pharmacother. 1998;52(9):349-55.    [Related articles]

Ohnishi Y, et al. Re: Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J Natl Cancer Inst. 1998 Dec 16;90(24):1909-11.    [Related articles]

Ou XM, et al. The storage of noradrenaline, neuropeptide Y and chromogranins in and stoichiometric release from large dense cored vesicles of the undifferentiated human neuroblastoma cell line SH-SY5Y. Int J Mol Med. 1998 Jan;1(1):105-12.    [Related articles]

Sak K, et al. Pyrimidinoceptor potentiation by ATP in NG108-15 cells. FEBS Lett. 1998 Nov 13;439(1-2):107-9.    [Related articles]

Sivak LE, et al. A novel intron element operates posttranscriptionally To regulate human N-myc expression. Mol Cell Biol. 1999 Jan;19(1):155-63.    [Related articles]     MYCN Amplification

Yang HW, et al. A polyclonal antibody against synthetic peptide conserved in N-Myc protein reacts with water-soluble recombinant N-Myc protein. Oncol Rep. 1999 Jan;6(1):107-111.    [Related articles]     MYCN Amplification

Zaizen Y, et al. The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression. J Pediatr Surg. 1998 Dec;33(12):1765-70.    [Related articles]     MYCN Amplification

Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Sorry, no references Previous Issue of Recent Publications (1998/12/a)
Next Issue of Recent Publications (1999/02/a)
Back to NBL-PROF Home Page